NCT03853031

Brief Summary

Intraoperative fluid management is pivotal to successful outcome of major oncosurgeries . Adequate volume replacement to achieve optimal cardiac performance is critical to prevent any deleterious consequences of under resuscitation or fluid overload . Traditionally CVP monitoring has been tool to guide intraoperative fluid therapy and has poor reliability as indicator of volume status . Transesophageal Echocardiography measured LVEDA is more reliable and sensitive measure of left ventricular volume to guide intraoperative fluid therapy . Investigators plan the study comparing total fluid requirement and postoperative outcomes in two groups of patients receiving central venous pressure (CVP) guided Conventional Fluid Therapy (CFT) and Left ventricular end diastolic area( LVEDA) guided fluids for major oncosurgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 8, 2019

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 25, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2019

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2019

Completed
Last Updated

January 22, 2025

Status Verified

January 1, 2025

Enrollment Period

4 months

First QC Date

February 8, 2019

Last Update Submit

January 18, 2025

Conditions

Keywords

Fluid therapyLeft ventricular end diastolic areaCentral venous pressure

Outcome Measures

Primary Outcomes (1)

  • To calculate total intraoperative fluids required in TEE (study) and CVP (control) groups.

    During the surgery Study group will receive fluids ( crystalloids and bolus colloids) guided by LVEDA cm2 and Control group will receive fluids (crystalloids and bolus colloids) guided by CVP cms H20

    Upto 8 hours

Secondary Outcomes (3)

  • To compare serum lactate levels in millimols/litre

    upto 48 hours

  • To compare serum creatinine in milligrams per decilitre in both the groups

    Upto 48 hours.

  • Length of ICU stay

    Upto 10 days

Study Arms (2)

LVEDA guided intraoperative fluid therapy

ACTIVE COMPARATOR

Patients in TEE group will be given crystalloid fluids during surgery guided by LVEDA cm2 to be maintained between 10 -18 cm2 , if LVEDA \< 10 cm2 then 200ml colloid bolus will be given and increase in LVEDA noted.

Procedure: LVEDA cm2 guided intraoperative fluid in TEE /Study Group

CVP guided intraoperative fluid therapy

ACTIVE COMPARATOR

Patients in CVP group will be given crystalloid fluids during surgery guided by CVP values to be maintained between 10 -16 cms of water H2O ,if CVP value \< 10 cms H2O then 200 ml colloid bolus will be given and increase in CVP value noted.

Procedure: CVP guided intraoperative fluid in CVP / Control group

Interventions

Placement of Transoesophageal echocardiography probe in TEE group to measure Left ventricular end diastolic area cm2

LVEDA guided intraoperative fluid therapy

Ultrasound guided Internal Jugular Vein catheter placement in CVP group to measure CVP value cms H2O .

CVP guided intraoperative fluid therapy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing major abdominopelvic oncosurgeries .

You may not qualify if:

  • oesophageal varices
  • carcinoma oesophagus
  • carcinoma stomach
  • coagulopathies
  • duration of surgery exceeding 8 hours.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anita Kulkarni

Delhi, National Capital Territory of Delhi, 110085, India

Location

Related Publications (3)

  • Gutierrez MC, Moore PG, Liu H. Goal-directed therapy in intraoperative fluid and hemodynamic management. J Biomed Res. 2013 Sep;27(5):357-65. doi: 10.7555/JBR.27.20120128. Epub 2013 Mar 10.

    PMID: 24086168BACKGROUND
  • Cheung AT, Savino JS, Weiss SJ, Aukburg SJ, Berlin JA. Echocardiographic and hemodynamic indexes of left ventricular preload in patients with normal and abnormal ventricular function. Anesthesiology. 1994 Aug;81(2):376-87. doi: 10.1097/00000542-199408000-00016.

    PMID: 8053588BACKGROUND
  • Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013 Jul;41(7):1774-81. doi: 10.1097/CCM.0b013e31828a25fd.

    PMID: 23774337BACKGROUND

MeSH Terms

Interventions

COP protocol 2Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Anita Kulkarni, MD

    Rajiv Gandhi Cancer Institute & Research Centre , India

    PRINCIPAL INVESTIGATOR
  • Anita Kulkarni, M.D.

    Rajiv Gandhi Cancer Institute & Research Centre , India

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients will be randomly allotted to either TEE or CVP Group according to computer generated randomization thus will be masked .
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: During surgery Control group of patients will receive CVP guided fluids Study group of patients will receive TEE measured LVEDA guided fluids
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 8, 2019

First Posted

February 25, 2019

Study Start

January 6, 2019

Primary Completion

April 30, 2019

Study Completion

May 10, 2019

Last Updated

January 22, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations